Average Co-Inventor Count = 3.26
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (6 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (6 from 363 patents)
3. Johnson & Johnson Consumer Companies, Inc. (1 from 271 patents)
13 patents:
1. 8937096 - Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
2. 8853263 - Co-therapy for the treatment of epilepsy and related disorders
3. 8716231 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
4. 8691867 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
5. 8501791 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
6. 8497298 - Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
7. 8492431 - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
8. 7786311 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
9. 7375123 - 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
10. 7319107 - 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11. 7259146 - Neuroprotective peptides
12. 7049331 - 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
13. 6908902 - Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin